Imetelstat (Rytelo) for Myelodysplastic Syndromes

The FDA has approved imetelstat (Rytelo – Geron), a first-in-class telomerase inhibitor, for treatment of low- to intermediate-1 risk myelodysplastic syndromes (MDS) in adults with transfusion-dependent anemia requiring 4 or more red blood cell (RBC) units over 8 weeks who have not responded to, are no longer responding to, or are ineligible for erythropoiesis-stimulating agents (ESAs).

Publication Details

Journal
˜The œmedical letter on drugs and therapeutics/˜The œmedical letter
Published
2024-09-19
DOI
https://doi.org/10.58347/tml.2024.1712d
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Imetelstat (Rytelo) for Myelodysplastic Syndromes

˜The œmedical letter on drugs and therapeutics/˜The œmedical letter
Acute Myeloid Leukemia Research
article

Imetelstat (Rytelo) for Myelodysplastic Syndromes

article en

Abstract

The FDA has approved imetelstat (Rytelo – Geron), a first-in-class telomerase inhibitor, for treatment of low- to intermediate-1 risk myelodysplastic syndromes (MDS) in adults with transfusion-dependent anemia requiring 4 or more red blood cell (RBC) units over 8 weeks who have not responded to, are no longer responding to, or are ineligible for erythropoiesis-stimulating agents (ESAs).

˜The œmedical letter on drugs and therapeutics/˜The œmedical letterVol. 66(1712)
Good health and well-being
Openalex Percentile: Top 76%
Acute Myeloid Leukemia Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Imetelstat (Rytelo) for Myelodysplastic Syndromes · ˜The œmedical letter on drugs and therapeutics/˜The œmedical letter (2024) | TGRS Research Map | TGRS